Company News
Lord’s Mark Advances AI Breast Screening Trials
Lord’s Mark, with C‑MET, announced Phase 2 AI‑powered breast cancer screening trials starting Jan 2027 in India, USA, UK and Europe, targeting 98% accuracy.
The technology uses high‑precision thermal
